Popular Blood Pressure Drug Increases Risk of Skin Cancer

A new Danish research finds that one of the most popular blood pressure drug used around the globe to treat hypertension can increase the risk of developing skin cancer by seven times.blood pressure drug

A team of scientists, led by Anton Pottegard, associate professor of clinical pharmacology at the University of Southern Denmark in Odense, examined the association between the common drug hydrochlorothiazide (HCTZ) and the risk of non-melanoma skin cancer.

Having analyzed the data of over 80,000 patients, the researchers found that those who took HTCS had 7 times higher chances to develop skin cancer.

Anton Pottergard comments: “We knew that hydrochlorothiazide made the skin more vulnerable to damage from the sun’s UV rays, but what is new and also surprising is that long-term use of this blood pressure medicine leads to such significant increase in the risk of skin cancer.”